Those are the results of an early trial.
US biotech company Moderna says their vaccine has produced antibodies to Coronavirus in all patients so far in their early trial.
As reported by CNBC, “This should further increase confidence that we are getting a robust immune response, in that there should be greater confidence that this will be protective to a degree in transmission of Covid,” Michael Yee, a managing director at Jefferies, said on CNBC’s “Fast Money.” “This is all along our positive thesis and our view that both Moderna and Pfizer-BioNTech are definitely on a good track to get a vaccine by the end of the year.”
So far, Moderna is in an early stage human trial, with all 45 patients having developed ‘neutralizing antibodies’ to the virus after being given the vaccine.
The positive news led to more hope of an economic recovery, with Dow Futures rising 300 points.
Moderna shares also increased in after-hours trading, up 12%.
While US companies near a vaccine, the Canadian government has faced criticism for the appalling decision to partner with the Chinese Communist Military on a CCP Virus vaccine – including testing it on Canadians.
Photo – YouTube